Ashland announces the launch of Perfectyl biofunctional, a novel high-tech chamomile extract, developed using Zeta Fraction technology, driven by Artificial Intelligence (A.I.) and inspired by new aesthetic techniques for relaxing facial lines without the need for injections.

Organically and sustainably sourced from the picturesque mountains in Oregon (USA), chamomile is an extraordinary medicinal herb from the pharmacopeia with well-known calming and relaxing properties. Using Ashland patented and sustainable Zeta Fraction technology, Ashland reveals a new side of chamomile in a natural extract with exceptional composition, naturally rich in GABA amino acid and flower acids.

Initially predicted by artificial intelligence (AI), Perfectyl addresses GABA pathway through GABAA expression ex vivo. GABA amino acid is a new target for beauty, known to be a facial line relaxer.

“Recent studies show that GABA is associated with skin pigmentation, remodeling, and muscle relaxation,” said Isabelle Imbert, PhD, R&D director, Ashland. “GABA amino acid is a neurotransmitter described to be the new natural cosmetic alternative solution to botox1 as facial line expression relaxer².”

“The younger generation of women are increasingly using non-surgical aesthetic procedures to get flawless skin, and this trend is driven by social media with billions of views,” said Justine Cotton, global marketing, biofunctionals, Ashland. “Inspired by these new aesthetic practices used by GenZ and Millennials to achieve a perfect skin, Ashland has developed Perfectyl to help smooth fine lines, refine enlarged pores, clarify imperfections and uneven skin, specifically pigment spots.”

Perfectyl targets multiple flaws induced by external and lifestyle stresses, such as post-inflammatory-hyperpigmentation and sebum overproduction.